NAGIOS: RODERIC FUNCIONANDO

Jaw osteonecrosis management around a dental implant inserted 2 years before starting treatment with zoledronic acid

Repositori DSpace/Manakin

IMPORTANT: Aquest repositori està en una versió antiga des del 3/12/2023. La nova instal.lació está en https://roderic.uv.es/

Jaw osteonecrosis management around a dental implant inserted 2 years before starting treatment with zoledronic acid

Mostra el registre parcial de l'element

dc.contributor.author Marín Fernández, A.B. es
dc.contributor.author García Medina, Blas es
dc.contributor.author Aguilar Salvatierra, Antonio es
dc.contributor.author Jiménez Burkhardt, Alberto es
dc.contributor.author Gómez Moreno, Gerardo es
dc.date.accessioned 2015-09-21T08:57:22Z
dc.date.available 2015-09-21T08:57:22Z
dc.date.issued 2015 es
dc.identifier.citation Marín Fernández, A.B. ; García Medina, Blas ; Aguilar Salvatierra, Antonio ; Jiménez Burkhardt, Alberto ; Gómez Moreno, Gerardo. Jaw osteonecrosis management around a dental implant inserted 2 years before starting treatment with zoledronic acid. En: Journal of Clinical and Experimental Dentistry, 2015, Vol. 7, No. 3: 444-446 es
dc.identifier.uri http://hdl.handle.net/10550/47189
dc.description.abstract Bisphosphonates (BP) are a type of drug known to inhibit bone resorption through complex interventions. Their primary mechanism of action is aimed at the cellular level, inhibiting osteoclast activity and so bone resorption. BPs are widely used, with many patients receiving continuous treatment for years. But it is well known that these drugs can produce osteonecrosis of the jaw (ONJ). Zoledronic acid (ZA) is an intravenous BP used in the treatment and prophylaxis of bone disease in patients with malignant tumors with bone implication. ZA is the most potent BP in clinical development. This report describes the case of a 62-year-old woman with breast cancer antecedents which relapsed, who had received a maxillary dental implant two years before the start of therapy with zoledronic acid. She later developed osteonecrosis of the jaw (ONJ), which began in the peri-implant area, and was treated for stage 3 ONJ by sub-total maxillectomy en_US
dc.subject Odontología es
dc.subject Ciencias de la salud es
dc.title Jaw osteonecrosis management around a dental implant inserted 2 years before starting treatment with zoledronic acid es
dc.type journal article es_ES
dc.subject.unesco UNESCO::CIENCIAS MÉDICAS es
dc.type.hasVersion VoR es_ES

Visualització       (1.483Mb)

Aquest element apareix en la col·lecció o col·leccions següent(s)

Mostra el registre parcial de l'element

Cerca a RODERIC

Cerca avançada

Visualitza

Estadístiques